Patents by Inventor Patricia Vrignaud

Patricia Vrignaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN
    Publication number: 20190275147
    Abstract: Disclosed are antitumor combinations of VEGF inhibitors with Irinotecan and the use thereof in the treatment of neoplastic diseases.
    Type: Application
    Filed: February 11, 2019
    Publication date: September 12, 2019
    Inventors: Marie-Christine BISSERY, Marielle CHIRON-BLONDEL, Pascale LEJEUNE, Patricia VRIGNAUD
  • ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATIN
    Publication number: 20180153931
    Abstract: The present invention relates to a combination comprising cabazitaxel and cisplatin. The present invention relates also to a pharmaceutical composition containing such a combination and to a pharmaceutical kit comprising: (i) a first galenic formulation comprising cabazitaxel; and (ii) a second galenic formulation comprising cisplatin. The invention relates also to the use of this combination and/or pharmaceutical composition and/or pharmaceutical kit in the treatment of neoplastic diseases, more particularly in the treatment of cancer.
    Type: Application
    Filed: July 13, 2017
    Publication date: June 7, 2018
    Inventors: Marie-Christine BISSERY, Jean-Francois DEDIEU, Akbar KHAN, Patricia VRIGNAUD
  • ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYCLOPHOSPHAMIDE
    Publication number: 20170056496
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and cyclophosphamide.
    Type: Application
    Filed: August 12, 2016
    Publication date: March 2, 2017
    Inventors: Pascale LEJEUNE, Patricia VRIGNAUD
  • Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan
    Patent number: 9259406
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and melphalan.
    Type: Grant
    Filed: November 27, 2009
    Date of Patent: February 16, 2016
    Assignee: SANOFI
    Inventors: Pascale Lejeune, Patricia Vrignaud
  • PEDIATRIC USES OF CABAZITAXEL
    Publication number: 20140350273
    Abstract: The present invention relates to the compound of formula (I): which may be in the form of an anhydrous base, a hydrate or a solvate, for its use for the treatment of pediatric cancers.
    Type: Application
    Filed: August 7, 2014
    Publication date: November 27, 2014
    Inventors: Sidhu S. SUKHVINDER, Patricia VRIGNAUD
  • ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN
    Publication number: 20140127202
    Abstract: Disclosed are antitumor combinations of VEGF inhibitors with Irinotecan and the use thereof in the treatment of neoplastic diseases.
    Type: Application
    Filed: January 13, 2014
    Publication date: May 8, 2014
    Applicant: Aventis Pharma S.A.
    Inventors: Marie-Christine BISSERY, Marielle CHIRON-BLONDEL, Pascale LEJEUNE, Patricia VRIGNAUD
  • ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATIN
    Publication number: 20140056996
    Abstract: The present invention relates to a combination comprising cabazitaxel and cisplatin. The present invention relates also to a pharmaceutical composition containing such a combination and to a pharmaceutical kit comprising: (i) a first galenic formulation comprising cabazitaxel; and (ii) a second galenic formulation comprising cisplatin. The invention relates also to the use of this combination and/or pharmaceutical composition and/or pharmaceutical kit in the treatment of neoplastic diseases, more particularly in the treatment of cancer.
    Type: Application
    Filed: August 22, 2013
    Publication date: February 27, 2014
    Applicant: Aventis Pharma S.A.
    Inventors: Marie-Christine BISSERY, Jean-Francois DEDIEU, Akbar KHAN, Patricia VRIGNAUD
  • Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine
    Patent number: 8633301
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and vincristine.
    Type: Grant
    Filed: November 27, 2009
    Date of Patent: January 21, 2014
    Assignee: Sanofi
    Inventors: Pascale Lejeune, Patricia Vrignaud
  • Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
    Patent number: 8388963
    Abstract: This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: March 5, 2013
    Assignees: Aventis Pharma SA, Regeneron Pharmaceuticals Inc
    Inventors: Patricia Vrignaud, Marielle Chiron-Blondel, Marie-Christine Bissery, Eric Furfine, Jocelyn Holash, Jesse M. Cedarbaum
  • ANTITUMOR COMBINATION INCLUDING AVE8062 AND SORAFENIB
    Publication number: 20120108641
    Abstract: Combinations comprising AVE8062 and sorafenib are provided which are effective in the treatment of cancers, more particularly of solid tumours.
    Type: Application
    Filed: November 3, 2011
    Publication date: May 3, 2012
    Applicant: SANOFI
    Inventors: Brigitte DEMERS, Patricia VRIGNAUD
  • ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYTARABINE
    Publication number: 20120093806
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and cytarabine.
    Type: Application
    Filed: November 27, 2009
    Publication date: April 19, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Pascale Lejeune, Patricia Vrignaud
  • ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYCLOPHOSPHAMIDE
    Publication number: 20110305690
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and cyclophosphamide.
    Type: Application
    Filed: November 27, 2009
    Publication date: December 15, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Pascale Lejeune, Patricia Vrignaud
  • ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND VINCRISTINE
    Publication number: 20110293606
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and vincristine.
    Type: Application
    Filed: November 27, 2009
    Publication date: December 1, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Pascale Lejeune, Patricia Vrignaud
  • ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND MELPHALAN
    Publication number: 20110274686
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and melphalan.
    Type: Application
    Filed: November 27, 2009
    Publication date: November 10, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Pascale Lejeune, Patricia Vrignaud
  • Combination Comprising Combretastatin and Anticancer Agents
    Publication number: 20110054035
    Abstract: This invention relates to therapeutic combinations comprising VEGF Trap and a stilbene derivative, and to methods for treatment of cancer comprising administration of such combinations.
    Type: Application
    Filed: November 9, 2010
    Publication date: March 3, 2011
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Marie-Christine BISSERY, Patricia VRIGNAUD, Marielle CHIRON-BLONDEL, Brigitte DEMERS
  • Combination comprising combretastatin and anticancer agents
    Patent number: 7851443
    Abstract: This invention relates to therapeutic combinations comprising VEGF Trap and a stilbene derivative, and to methods for treatment of cancer comprising administration of such combinations.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: December 14, 2010
    Assignee: Aventis Pharma SA
    Inventors: Marie-Christine Bissery, Patricia Vrignaud, Marielle Chiron-Blondel, Brigitte Demers
  • ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN
    Publication number: 20100160233
    Abstract: Disclosed are antitumor combinations of VEGF inhibitors with Irinotecan and the use thereof in the treatment of neoplastic diseases.
    Type: Application
    Filed: January 4, 2010
    Publication date: June 24, 2010
    Applicant: Aventis Pharma S.A.
    Inventors: Marie-Christine BISSERY, Marielle CHIRON-BLONDEL, Pascale LEJEUNE, Patricia VRIGNAUD
  • ANTITUMOR COMBINATIONS CONTAINING A VEGF-INHIBITING AGENT AND 5FU OR A DERIVATIVE THEREOF
    Publication number: 20090285841
    Abstract: This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
    Type: Application
    Filed: July 24, 2009
    Publication date: November 19, 2009
    Applicants: AVENTIS PHARMA SA, REGENERON PHARMACEUTICALS INC.
    Inventors: Patricia VRIGNAUD, Marielle CHIRON-BLONDEL, Marie-Christine BISSERY, Eric FURFINE, Jocelyn HOLASH, Jesse M. CEDARBAUM
  • ANTITUMOR COMBINATIONS CONTAINING TAXANE DERIVATIVES
    Publication number: 20090196869
    Abstract: The disclosure relates to pharmaceutical combinations comprising acetylcyclopropyl docetaxel and a monoclonal antibody against ErbB2, and to methods of use thereof.
    Type: Application
    Filed: January 21, 2009
    Publication date: August 6, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Marie-Christine BISSERY, Patricia VRIGNAUD, Claudia FROMOND
  • Combination Comprising Combretastatin and Anticancer Agents
    Publication number: 20090023656
    Abstract: This invention relates to therapeutic combinations comprising VEGF Trap and a stilbene derivative, and to methods for treatment of cancer comprising administration of such combinations.
    Type: Application
    Filed: June 19, 2008
    Publication date: January 22, 2009
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Marie-Christine BISSERY, Patricia VRIGNAUD, Marielle CHIRON-BLONDEL, Brigitte DEMERS